AUTHERA AS
928956164ActiveDeveloping novel FcRn-targeting biologics for therapeutic applications.
Pre-clinical Biotechnology Companyauthera.bio
Yleiskatsaus
- 6
- Työntekijät
- 10.6milj NOK
- Liikevaihto
- 2022
- Perustettu
Avainpäättäjät
Jan Terje Andersen
Chairman & Co-founder
@authera.bio
Inger Sandlie
Board member & Co-founder
@authera.bio
Torleif T. Gjølberg
CSO & Co-founder
@authera.bio
Hans Petter Tjeldflaat
CFO
@authera.bio
+5 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Authera is a pre-clinical biotechnology company established in 2022 as a spin-off from Oslo University Hospital and the University of Oslo. The organization is dedicated to developing novel therapeutic biologics based on proprietary research into albumin and antibody-based molecules. Their core asse...
OxThera Intellectual Property AB